MHRA Policy Paper: Impact of Artificial Intelligence on the Regulation of Medical Products
Report
Free
This policy paper provides an update on the Medicines and Healthcare products Regulatory Agency’s (MHRA) use of artificial intelligence (AI):
- As a regulator
- As a public service organisation delivering time-critical decisions
- As an organisation making evidence-based decisions that impact public safety
This policy paper was published in April 2024.
Added on: 09 October 2024